News
Cisbio's HTRF® KinEASEâ„¢ assay for screening serine/threonine kinases now extends to tyrosine kinases (TK). The assay, developed in partnership with Millipore, uses a unique substrate containing ...
Cisbio’s powerful HTRF technology allows for easy and thorough investigation into your GPCR targets of interest. Assays kits are available either ready to use, or you can easily have your own custom ...
Shenzhen Zhongge Biotechnology Co. Ltd. has described tyrosine-protein phosphatase non-receptor type 2 (PTPN2; TCPTP) inhibitors reported to be useful for the treatment of cancer, type 2 diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results